New Delhi | 18th December 2025: Shardul Amarchand Mangaldas & Co. (SAM) advised Medi Assist Healthcare Services Limited (“Medi Assist”) on its ~INR 198 crores fundraise through preferential issue of equity shares to Massachusetts Institute of Technology (MIT) and 238 Plan Associates LLC (collectively, the “Investors”).
The transaction involved the issuance and allotment of fully paid-up equity shares of Medi Assist on a preferential basis to the Investors, who are qualified institutional buyers and SEBI-registered foreign portfolio investors. Following the Preferential Issue, Massachusetts Institute of Technology and 238 Plan Associates LLC hold 3.86% and 1.08%, respectively, of the total share capital of Medi Assist. IIFL Capital Services Limited acted as the financial advisor to the transaction.
The SAM team was led by Prashant Gupta, National Practice Head — Capital Markets; Devesh Pandey, Partner, along with Jasmine Khan, Senior Associate; Anushka Ganguli, Associate; and Sourav Paul, Associate.